Including Parikh, the other members of the research team are Heather Thiessen-Philbrook, M.MATH, and Allen Everett, M.D., from the Johns Hopkins University School of Medicine (Baltimore, Maryland); Jason Greenberg, M.D., from Yale University (New Haven, Connecticut); Eric McArthur, M.Sc., from ICES (Toronto, Ontario, Canada); Ron Wald, M.D., C.M., from St. Michael's Hospital and the University of Toronto (Toronto, Ontario, Canada); Michael Zappitelli, M.D., M.Sc., from The Hospital for Sick Children (Toronto, Ontario, Canada); Rahul Chanchlani, M.D., from McMaster University (Hamilton, Ontario, Canada); and Amit X. Garg, M.D., Ph.D., from Western University (London, Ontario, Canada).
The study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (Toronto, Ontario, Canada). Parikh reports personal fees for consulting from Akebia Therapeutics Inc. and Genfit Biopharmaceutical Company, and other fees from Renaltix AI. None of the other authors have anything to disclose.
Back to HCB News